IRF-1 and IRF-2 were originally discovered as the critical regulators of the interferon system; modulating the expression of the interferon- beta (IFN-beta) gene in response to viral infection. The roles of IRF-1/2 have since multiplied to include tumor-suppression (IRF-1) and oncogenic properties (IRF-2). Deletion and/or inactivation of IRF-1 has been shown to be a critical step in the development of some human leukemias. To understand how IRF-1 and IRF-2 regulate the IFN-beta gene, we propose biochemical and structural studies aimed at understanding how they recognize their target DNA sites, manifest their repression/activation activities, and how IRF-1 interacts with adjacently bound coactivators such as NK-kappaB and HMG I(Y).
The specific aims of this proposal are: (1) To characterize the structure and function of IRF-1. We have shown that IRF-1 is accommodated differently when bound to the PRD I element versus the PRD III element of the IFN-Beta promoter. This distinction is important in vivo. We will determine the structure of IRF-1 bound to the PRD III element using molecular replacement methods. We will also examine the role of residues outside of the DNA binding domain using biophysical and in vivo transfection methods. To complement these studies, we will determine the thermodynamic parameters underlying IRF-1-DNA recognition by isothermal titration calorimetry. (2) To characterize the structure and function of IRF-2. IRF-1 and IRF-2 share similarities throughout their sequence, but manifest opposing transcriptional activities. There are also unexpected differences in the DNA binding properties of the two proteins. We will determine the structure of IRF-2 bound to the PRD I element and compare it with the IRF-1/PRD I structure. We will swap regions between the two proteins in order to interchange their transcriptional activities. The transcription levels will be measured by transfection assays using reporter plasmids. (3) To determine the structural basis of transcriptional synergy between IRF-1, NF-kappaB, and HMG I(Y). We have shown that IRF-1 and NF-kappaB inhibit each other's DNA binding, but that this inhibition can be relieved by the addition of HMG I(Y). As part of our long term goal, we will characterize these complexes through analytical ultracentrifugation studies, and attempt to cocrystallize IRF-1, NF-kappaB, and HMG I(Y) as a quaternary complex. We will delete the N-terminal arm of IRF-1 in order to test our hypothesis of steric interference between IRF-1 and NF-kappaB.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
1R01AI041706-01A1
Application #
2692911
Study Section
Molecular and Cellular Biophysics Study Section (BBCA)
Project Start
1998-06-01
Project End
2003-04-30
Budget Start
1998-06-01
Budget End
1999-04-30
Support Year
1
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Physiology
Type
Schools of Medicine
DUNS #
114400633
City
New York
State
NY
Country
United States
Zip Code
10029
Malu, Shruti; De Ioannes, Pablo; Kozlov, Mikhail et al. (2012) Artemis C-terminal region facilitates V(D)J recombination through its interactions with DNA Ligase IV and DNA-PKcs. J Exp Med 209:955-63
De Ioannes, Pablo; Escalante, Carlos R; Aggarwal, Aneel K (2011) Structures of apo IRF-3 and IRF-7 DNA binding domains: effect of loop L1 on DNA binding. Nucleic Acids Res 39:7300-7
Nistal-Villán, Estanislao; Gack, Michaela U; Martínez-Delgado, Gustavo et al. (2010) Negative role of RIG-I serine 8 phosphorylation in the regulation of interferon-beta production. J Biol Chem 285:20252-61
Joshi, Rohit; Passner, Jonathan M; Rohs, Remo et al. (2007) Functional specificity of a Hox protein mediated by the recognition of minor groove structure. Cell 131:530-43
Escalante, Carlos R; Nistal-Villan, Estanislao; Shen, Leyi et al. (2007) Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer. Mol Cell 26:703-16
James, J Anson; Aggarwal, Aneel K; Linden, R Michael et al. (2004) Structure of adeno-associated virus type 2 Rep40-ADP complex: insight into nucleotide recognition and catalysis by superfamily 3 helicases. Proc Natl Acad Sci U S A 101:12455-60
Yoon-Robarts, Miran; Blouin, Amanda G; Bleker, Svenja et al. (2004) Residues within the B' motif are critical for DNA binding by the superfamily 3 helicase Rep40 of adeno-associated virus type 2. J Biol Chem 279:50472-81
James, J Anson; Escalante, Carlos R; Yoon-Robarts, Miran et al. (2003) Crystal structure of the SF3 helicase from adeno-associated virus type 2. Structure 11:1025-35
Escalante, Carlos R; Brass, Abraham L; Pongubala, Jagan M R et al. (2002) Crystal structure of PU.1/IRF-4/DNA ternary complex. Mol Cell 10:1097-105
Escalante, Carlos R; Shen, Leyi; Thanos, Dimitris et al. (2002) Structure of NF-kappaB p50/p65 heterodimer bound to the PRDII DNA element from the interferon-beta promoter. Structure 10:383-91

Showing the most recent 10 out of 11 publications